Answers are grounded in this paper and cite their sources.
High-intensity rosuvastatin therapy over 13 months is associated with regression of coronary atherosclerosis in non-infarct-related arteries without changes in RF-IVUS defined necrotic core or plaque phenotype among STEMI patients.
No takes yet. Share an insight, caveat, or question.
Räber et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: